Home Infusion Therapy Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Home Infusion Therapy Devices Market By device Type (Infusion Pump, Needleless Connectors, Intravenous Set, Others), By Pump Type (Enteral Infusion Pump, Insulin Infusion Pump, Syringe Infusion Pump, Patient-Controlled Analgesia, Volumetric Infusion Pump, Others), By Application (Infectious Diseases, Pain Management, Enteral Nutrition, Chemotherapy, Total Parenteral Nutrition, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Home Infusion Therapy Devices Market size was valued at USD 23.3 billion in 2021 and is expected to reach a value USD 53.7 billion by 2028, at a CAGR of 11% during the forecast period 2022-2028. Infusion therapy has become a common technique of pain relief, particularly for conditions when oral medicine is ineffective. The medication is frequently given intravenously or subcutaneously in this method. Patients are converting from traditional therapies to specialised infusion therapy treatments as a result of technological advancements. Home infusion therapy devices are used to administer drug solutions to treat various diseases that are unresponsive to the oral medication such as gastrointestinal diseases, cancer, and pain. Home infusion therapy declines the unplanned hospitalization and also improves the medication adherence. Most commonly used home infusion therapy devices for drug administration include intravenous set, needleless connectors, and infusion pumps among others. Due to increase in the prevalence of chronic diseases majorly diabetes and cancer and increase in awareness are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, technological advancements such as the introduction of smart pumps that enhancing the overall ease of using home infusion devices are expected to drive market revenue. Furthermore, acquisitions and mergers, collaborations, and product launchings are the key strategies followed by the market players for generating larger revenue in the home infusion therapy devices market. For instance, in March 2016, PromptCare acquired Boston Home Infusion for expanding the product portfolio in Boston area. Similarly, in October 2016, ICU Medical Inc. acquired Hospira Infusion Systems for strengthening its home infusion therapy devices portfolio.

Key Developments:

In April 2017, Becton, Dickinson and company acquired Caesarea Medical Electronics for strengthening infusion system portfolio including home infusion therapy devices

Home Infusion Therapy Devices Market

MARKET SUMMARY
-
11%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 11%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Home Infusion Therapy Devices Market

  • The report on global home infusion therapy devices market gives historical, current and future market sizes (US$ Bn) based on device type, pump type, application, application and region.
  • home infusion therapy devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Fresenius Kabi AG
  • Braun Melsungen AG
  • ICU Medical, Inc.
  • Terumo Corporation
  • JMS Co. Ltd.
Home Infusion Therapy Devices Market Drivers And Restraints

Increase in the demand for home infusion therapy from patients, high cost for hospitalization treatment, a wide range of applications with infusion devices, and presence of unmet medical needs are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, increase in geriatric population, technological developments in home infusion therapy devices, and high prevalence of chronic diseases like diabetes and cancer are expected to boost the home infusion therapy devices market over the forecast period. However, the risk associated with the drug administration, product recalls, unfavorable reimbursement policies and misguidance about the usage of the device are impede the growth of home infusion therapy devices market over the forecast years.


North-America Got Significant Share

Home Infusion Therapy Devices Market

Geographically, global home infusion therapy devices market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americahome infusion therapy devices market growing due to increase in the awareness about home infusion therapy devices among key stakeholders, favorable reimbursement policies, and innovation of novel products are boosting the market. Europe home infusion therapy devices market expected to grow at a significant rate due to acquisitions between the companies for instance, in January 2015, Air Liquide acquired Optical Medical Therapies for expansion of business in German home infusion market. Asia Pacific expected to hold significant share owing to rise in patient awareness about home infusion therapy devices, adoption of newer devices, an increase in awareness about the advantages of home infusion therapy devices in the region. Latin Americahome infusion therapy devices market is projected to grow at a significant rate, which is attributed to the expansion of businesses by the market players, increase in the prevalence of cancer, and increase in geriatric population.Middle East and Africa driven by developing healthcare infrastructure and increase in the prevalence of chronic diseases like AIDS, cancer, and among others.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Home Infusion Therapy Devices Market report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market.

Key

Key Features of the Report

Home Infusion Therapy Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The home infusion therapy devices market is projected to expand at a CAGR of 11% during the forecast period

Fresenius Kabi AG, Braun Melsungen AG, ICU Medical, Inc, Terumo Corporation, JMS Co. Ltd.

North America is the fastest-growing region for home infusion therapy devices market


Report

Table Of Content


Report

Company Profile

  • Fresenius Kabi AG (Germany)
  • Braun Melsungen AG (Germany)
  • ICU Medical, Inc. (U.S.)
  • Terumo Corporation (Japan)
  • JMS Co. Ltd. (Japan)
  • Smiths Medical (U.S.)
  • Baxter International Inc. (U.S.)
  • Caesarea Medical Electronics Ltd. (Becton, Dickinson and Company) (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)

Description

Home Infusion Therapy Devices Market size was valued at USD 23.3 billion in 2021 and is expected to reach a value USD 53.7 billion by 2028, at a CAGR of 11% during the forecast period 2022-2028. Infusion therapy has become a common technique of pain relief, particularly for conditions when oral medicine is ineffective. The medication is frequently given intravenously or subcutaneously in this method. Patients are converting from traditional therapies to specialised infusion therapy treatments as a result of technological advancements. Home infusion therapy devices are used to administer drug solutions to treat various diseases that are unresponsive to the oral medication such as gastrointestinal diseases, cancer, and pain. Home infusion therapy declines the unplanned hospitalization and also improves the medication adherence. Most commonly used home infusion therapy devices for drug administration include intravenous set, needleless connectors, and infusion pumps among others. Due to increase in the prevalence of chronic diseases majorly diabetes and cancer and increase in awareness are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, technological advancements such as the introduction of smart pumps that enhancing the overall ease of using home infusion devices are expected to drive market revenue. Furthermore, acquisitions and mergers, collaborations, and product launchings are the key strategies followed by the market players for generating larger revenue in the home infusion therapy devices market. For instance, in March 2016, PromptCare acquired Boston Home Infusion for expanding the product portfolio in Boston area. Similarly, in October 2016, ICU Medical Inc. acquired Hospira Infusion Systems for strengthening its home infusion therapy devices portfolio.

Key Developments:

In April 2017, Becton, Dickinson and company acquired Caesarea Medical Electronics for strengthening infusion system portfolio including home infusion therapy devices

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX